Researchers in Zurich are pioneering major advancements in lab-made, hydrogel-based corneal implants to address global donor shortages and treat severe eye conditions like keratoconus. These innovations remain in the research phase and are not yet available for standard clinical treatments or commercial purchase. [1, 2, 3]
Leading the charge are two notable institutional projects in the city: [1]
Augel (ETH Zurich): Spearheaded by ETH Pioneer Fellow Dr. Shuo Li, this project is developing a soft, mini-sized hydrogel implant made from functionalized collagen. The implant is designed to be inserted via minimally invasive laser procedures to stabilise the cornea, eliminate the need for human donors, and restore vision. [1, 2, 3]
To learn more about the progress of these studies, you can visit the ETH Zurich News portal or the Empa Ophthalmology department page. For currently available medical treatments or inquiries regarding your vision, you should consult your local ophthalmologist.